Healthcare

Sobi Receives European Commission Approval for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

STOCKHOLM, Jan. 16, 2026, 06:49 GMT-05

SOBI-EU-Approval

Read full article →

Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs

PARIS, Jan. 16, 2026, 05:05 GMT-05

Datwyler-tech

Read full article →

Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market

HANGZHOU, China and BERLIN, Jan. 16, 2026, 21:27 GMT-05

ZyloxTonbridgeAcquire

Read full article →

Hemophagocytic Lymphohistiocytosis Market Poised for Phenomenal Expansion in the US at a CAGR of 24.5% During the Forecast Period (2025-2034) | DelveInsight

LAS VEGAS, Jan. 15, 2026, 17:31 GMT-05

DELVEINSIGHT-HLH

Read full article →

Cancer Biomarkers Market Surges to USD 45.7 Billion by 2033, Propelled by 8.6% CAGR - Verified Market Reports®

LEWES, Del., Jan. 15, 2026, 10:43 GMT-05

VERIFIED-MKT-REPORT

Read full article →

Global Digital Immunoassays Market to Hit USD 7.1 Billion by 2036; High Demand for Ultra-High Sensitivity Testing Drives 11.4% CAGR

NEWARK, Del., Jan. 15, 2026, 10:30 GMT-05

FMI-digital-immuno

Read full article →

Canine Urolithiasis Treatment Market to Reach USD 4.3 Billion by 2036 as Preventive Pet Healthcare Gains Global Momentum

NEWARK, Del., Jan. 15, 2026, 09:10 GMT-05

fmi-canine-urolith-tx

Read full article →

BLOODPAC Publishes New Standards for Liquid Biopsy Tests That Monitor for Cancer Recurrence

CHICAGO, Jan. 15, 2026, 07:00 GMT-05

BLOODPAC-JCO

Read full article →

First Patients in the UK Receive Doses of Blue Earth Therapeutics' Investigational Radiopharmaceutical Therapy Lutetium (177Lu) rhPSMA-10.1 Injection for Metastatic Castrate Resistant Prostate Cancer

OXFORD, England, Jan. 15, 2026, 01:01 GMT-05

Lutetium-prostate-tx

Read full article →

House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight

LAS VEGAS, Jan. 14, 2026, 17:31 GMT-05

DELVEINSIGHT

Read full article →

Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease

BOLOGNA, Italy and MUNICH, Jan. 14, 2026, 12:38 GMT-05

Innovative-Molecules

Read full article →

Pharmaceutical Filtration Consumables Market worth $18.03 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 14, 2026, 10:30 GMT-05

MARKETSANDMARKETS

Read full article →

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences

LOS GATOS, Calif., Jan. 14, 2026, 08:00 GMT-05

LynxAnalyticsLumen

Read full article →

Meaco secures significant strategic investment to accelerate European growth

LONDON, Jan. 14, 2026, 05:00 GMT-05

Meaco-Investment

Read full article →

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program

SEOUL, South Korea, Jan. 14, 2026, 18:46 GMT-05

LOTTE-BIOLOGICS

Read full article →

Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight

LAS VEGAS, Jan. 13, 2026, 17:31 GMT-05

DELVEINSIGHT

Read full article →

Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease Control

AUSTIN, Texas and TOKYO, Jan. 13, 2026, 10:15 GMT-05

DATAM-INTELLIGENCE

Read full article →

n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

SAN DIEGO and GENEVA, Jan. 13, 2026, 09:09 GMT-05

ESPERARE-FOUNDATION

Read full article →

Ability Center brings Cognoa's Canvas Dx to Saudi Arabia, giving families faster, more precise autism evaluations in early childhood

NEWPORT BEACH, Calif., Jan. 13, 2026, 09:00 GMT-05

COGNOA-Canvas-Dx-SA

Read full article →

ESTEVE to acquire TerSera Therapeutics' Infusion Specialty Therapies Business Unit, Expanding U.S. presence

BARCELONA, Spain and DEERFIELD, Ill., Jan. 13, 2026, 03:45 GMT-05

ESTEVE-Acq-TerSera

Read full article →